Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture

Use of Osteoporosis Medications after Hospitalization for Hip Fracture: A Cross-national Study

(2015) Seoyoung C. Kim et al.   AMERICAN JOURNAL OF MEDICINE

Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis

(2015) Dae Hyun Kim et al.   PLoS One

Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011

(2014) Daniel H Solomon et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis

(2013) Lydia Gedmintas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteonecrosis of the Jaw in Sweden Associated With the Oral Use of Bisphosphonate

(2013) Mattias Ulmner et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention

(2012) John A Eisman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Incidence of atypical nontraumatic diaphyseal fractures of the femur

(2012) Richard M Dell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study

(2012) L. Bondo et al.   OSTEOPOROSIS INTERNATIONAL

Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges

(2012) D. H. Solomon et al.   OSTEOPOROSIS INTERNATIONAL

A combined comorbidity score predicted mortality in elderly patients better than existing scores

(2011) Joshua J. Gagne et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE